Form D Explorer

Form C — LexaGene Life Sciences CF Investors, Inc.

0001104659-23-112915 · filed 2023-10-31 · via DEALMAKER SECURITIES LLC

Offering

Target
$25,750
Maximum
$5,000,000
Security type
Common Stock
Price per security
$1.0300
Deadline
Oversubscription
Accepted

Issuer

CIK
1998226
Entity
Corporation
Jurisdiction
DE
Address
3811 TURTLE CREEK BLVD., STE 875
DALLAS, TX 75219
Phone

Most recent fiscal year financials

Total assets
$64,620
Cash
Short-term debt
Long-term debt
Revenues
COGS
$11,433
Taxes paid
Net income
$11,433

View original on SEC EDGAR.